The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be ...

Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding ...

A former FDA commissioner and a former Institute of Medicine president are teaming up to create the Vaccine Integrity Project ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

He is the head of HHS, and yet he continues to spout untested, unproven therapies and has only given a very lukewarm ...

The administration last month clawed back more than $11 billion of already approved and allocated federal health grants ...

Health experts warn if kids don’t get their measles shots, we may start to see millions of cases across the country.

Cutting these programs now is not just shortsighted, it’s dangerous,” the director of the Kansas City Health Department said.

As awareness of the measles outbreak spreads, many Americans are asking questions and reassessing their vaccination status.

Experts underscore the importance of MMR vaccinations to prevent the spread of measles and bolster collective immunity.

In March, the federal government pulled back $11.4 billion in promised funding for state and community health departments.